Pfizer and BioNTech has granted emergency use authorization of Omicron BA.4/BA.5-Adapted Bivalent Covid-19 vaccine booster for ages 12 years and older.

The Pfizer-BioNTech Omicron bivalent vaccine is expected to ship to pharmacies and hospitals immediately.

“As we head into the fall and winter season, with the potential for greater SARS-CoV-2 spread in schools and at work, it is important to stay up to date with vaccines as a first line of defense against COVID-19 illness,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “We are thrilled by today’s news, another important milestone in our ongoing efforts to provide protection against this virus.”